Medicina,
Journal Year:
2023,
Volume and Issue:
59(3), P. 594 - 594
Published: March 17, 2023
Metabolic-dysfunction-associated
fatty
liver
disease
(MAFLD)
is
the
recent
nomenclature
designation
that
associates
condition
of
non-alcoholic
(NAFLD)
with
metabolic
dysfunction.
Its
diagnosis
has
been
debated
in
period
and
generally
associated
a
steatosis
at
least
one
pathologic
among
overweight/obesity,
type
2
diabetes
mellitus,
dysregulation.
pathogenesis
defined
by
“multiple-hit”
model
alteration
or
dysbiosis
gut
microbiota.
The
pathogenic
role
microbiota
investigated
many
diseases,
including
obesity,
NAFLD.
However,
only
few
works
correlate
it
MAFLD,
although
common
pathogenetic
links
to
these
diseases
are
suspected.
This
review
underlines
most
recurrent
changes
patients
while
also
evidencing
possible
links.
Microorganisms,
Journal Year:
2022,
Volume and Issue:
11(1), P. 1 - 1
Published: Dec. 20, 2022
Ruminants
are
foregut
fermenters
that
have
the
remarkable
ability
of
converting
plant
polymers
indigestible
to
humans
into
assimilable
comestibles
like
meat
and
milk,
which
cornerstones
human
nutrition.
establish
a
symbiotic
relationship
with
their
microbiome,
latter
is
workhorse
carbohydrate
fermentation.
On
other
hand,
during
fermentation,
synthesis
propionate
sequesters
H,
thus
reducing
its
availability
for
ultimate
production
methane
(CH4)
by
methanogenic
archaea.
Biochemically,
simplest
alkane
represents
downturn
in
energetic
efficiency
ruminants;
environmentally,
it
constitutes
potent
greenhouse
gas
negatively
affects
climate
change.
Prevotella
very
versatile
microbe
capable
processing
wide
range
proteins
polysaccharides,
one
fermentation
products
propionate,
trait
appears
conspicuous
P.
ruminicola
strain
23.
Since
but
not
acetate
or
butyrate,
an
H
sink,
propionate-producing
microbes
potential
reduce
production.
Accordingly,
numerous
studies
suggest
members
genus
divert
hydrogen
flow
glycolysis
away
from
methanogenesis
favor
propionic
acid
Intended
broad
audience
microbiology,
our
review
summarizes
biochemistry
subsequently
discusses
evidence
supporting
essential
role
lignocellulose
association
reduced
emissions.
We
hope
this
article
will
serve
as
introduction
novice
researchers
update
others
more
conversant
topic.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(20), P. 4466 - 4466
Published: Oct. 21, 2023
The
gut
microbiome
is
a
diverse
bacterial
community
in
the
human
gastrointestinal
tract
that
plays
important
roles
variety
of
biological
processes.
Short-chain
fatty
acids
(SCFA)
are
produced
through
fermentation
dietary
fiber.
Certain
microbes
responsible
for
producing
SCFAs
such
as
acetate,
propionate
and
butyrate.
An
imbalance
diversity
can
lead
to
metabolic
disorders
inflammation-related
diseases.
Changes
SCFA
levels
associated
microbiota
were
observed
IBD,
suggesting
an
association
between
disease.
affect
reactive
oxygen
species
(ROS)
with
IBD.
Gut
closely
related
it
study
them
further.
Acta Diabetologica,
Journal Year:
2023,
Volume and Issue:
60(8), P. 1007 - 1017
Published: April 14, 2023
Abstract
Aims
The
purpose
of
this
review
is
to
explore
the
interconnected
pathways
microbiota-gut-brain
axis
(MGBA),
focusing
on
roles
vagus
nerve
and
glucagon
like
peptide-1
in
appetite
control,
development
obesity
diabetes.
Methods
Type
2
diabetes
mellitus
(T2DM)
are
metabolic
disorders
whose
prevalence
has
significantly
increased
recent
decades
expected
increase
every
year,
pandemic
proportions.
These
two
pathologies
often
coexist
have
substantial
public
health
implications.
term
“diabesity”
defines
pathophysiological
connection
between
overweight
T2DM.
gut
microbiota
affects
many
aspects
host.
Beyond
regulation
intestinal
functions
activation
immune
responses,
plays
a
role
central
nervous
system
(i.e.,
mood,
psychiatric
conditions
associated
with
stress
memory)
regulator
metabolism
appetite.
Results
MGBA
involves
such
as
autonomic
enteric
systems,
hypothalamic–
pituitary–adrenal
axis,
system,
enteroendocrine
cells,
microbial
metabolites.
Notably,
an
essential
eating
behavior
by
modulating
learning
nutritional
preferences.
Conclusions
Because
its
cell-mediated
interaction
microbiota,
may
provide
potential
pathway
through
which
microorganisms
influence
host
feeding
control
physiological
pathological
conditions.
Foods,
Journal Year:
2023,
Volume and Issue:
12(5), P. 1023 - 1023
Published: Feb. 28, 2023
Foods
contain
dietary
fibers
which
can
be
classified
into
soluble
and
insoluble
forms.
The
nutritional
composition
of
fast
foods
is
considered
unhealthy
because
it
negatively
affects
the
production
short-chain
fatty
acids
(SCFAs).
Dietary
fiber
resistant
to
digestive
enzymes
in
gut,
modulates
anaerobic
intestinal
microbiota
(AIM)
fabricates
SCFAs.
Acetate,
butyrate,
propionate
are
dominant
gut
generated
via
Wood–Ljungdahl
acrylate
pathways.
In
pancreatic
dysfunction,
release
insulin/glucagon
impaired,
leading
hyperglycemia.
SCFAs
enhance
insulin
sensitivity
or
secretion,
beta-cell
function,
leptin
release,
mitochondrial
gluconeogenesis
human
organs,
positively
type
2
diabetes
(T2D).
Research
models
have
shown
that
either
peptide
YY
(PYY)
glucagon-like
peptide-1
(GLP-1)
from
L-cells
(entero-endocrine),
promotes
hormone
adipose
tissues
through
G-protein
receptors
GPR-41
GPR-43.
a
component
influences
by
AIM,
may
beneficial
effects
on
T2D.
This
review
focuses
effectiveness
producing
colon
AIM
as
well
health-promoting
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(11), P. 5640 - 5640
Published: May 22, 2024
The
epidemiological
burden
of
liver
steatosis
associated
with
metabolic
diseases
is
continuously
growing
worldwide
and
in
all
age
classes.
This
condition
generates
possible
progression
damage
(i.e.,
inflammation,
fibrosis,
cirrhosis,
hepatocellular
carcinoma)
but
also
independently
increases
the
risk
cardio-metabolic
cancer.
In
recent
years,
terminological
evolution
from
“nonalcoholic
fatty
disease”
(NAFLD)
to
“metabolic
dysfunction-associated
(MAFLD)
and,
finally,
steatotic
(MASLD)
has
been
paralleled
by
increased
knowledge
mechanisms
linking
local
hepatic)
systemic
pathogenic
pathways.
As
a
consequence,
need
for
an
appropriate
classification
individual
phenotypes
oriented
investigation
innovative
therapeutic
tools.
Besides
well-known
role
lifestyle
change,
number
pharmacological
approaches
have
explored,
ranging
antidiabetic
drugs
agonists
acting
on
gut–liver
axis
at
level
(mainly
farnesoid
X
receptor
(FXR)
agonists,
PPAR
thyroid
hormone
agonists),
anti-fibrotic
anti-inflammatory
agents.
intrinsically
complex
pathophysiological
history
MASLD
makes
selection
single
effective
treatment
major
challenge,
so
far.
this
evolving
scenario,
cooperation
between
different
stakeholders
(including
subjects
risk,
health
professionals,
pharmaceutical
industries)
could
significantly
improve
management
disease
implementation
primary
secondary
prevention
measures.
high
healthcare
search
new,
effective,
safe
pressing
need,
together
accurate
characterization
phenotypes.
Recent
promising
advances
indicate
that
we
may
soon
enter
era
precise
personalized
therapy
MASLD/MASH.
FEBS Journal,
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 1, 2024
Huntington's
disease
(HD)
is
a
currently
incurable
neurogenerative
disorder
and
typically
characterized
by
progressive
movement
(including
chorea),
cognitive
deficits
(culminating
in
dementia),
psychiatric
abnormalities
(the
most
common
of
which
depression),
peripheral
symptoms
gastrointestinal
dysfunction).
There
are
no
approved
disease‐modifying
therapies
available
for
HD,
with
death
usually
occurring
approximately
10–25
years
after
onset,
but
some
hold
promising
potential.
HD
subjects
often
burdened
chronic
diarrhea,
constipation,
esophageal
gastric
inflammation,
susceptibility
to
diabetes.
Our
understanding
the
microbiota–gut–brain
axis
its
infancy
growing
evidence
from
preclinical
clinical
studies
suggests
role
gut
microbial
population
imbalance
(gut
dysbiosis)
pathophysiology.
The
brain
can
communicate
through
enteric
nervous
system,
immune
vagus
nerve,
microbiota‐derived‐metabolites
including
short‐chain
fatty
acids,
bile
branched‐chain
amino
acids.
This
review
summarizes
supporting
demonstrating
alterations
bacterial
fungal
composition
that
may
be
associated
HD.
We
focus
on
mechanisms
dysbiosis
compromise
health,
thus
triggering
neuroinflammatory
responses,
further
highlight
outcomes
attempts
modulate
microbiota
as
therapeutic
strategies
Ultimately,
we
discuss
dearth
data
need
more
longitudinal
translational
this
nascent
field.
suggest
future
directions
improve
our
association
between
microbes
pathogenesis
other
‘brain
body
disorders’.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2024,
Volume and Issue:
14
Published: Feb. 16, 2024
Abnormal
behavior
of
α-synuclein
and
prion
proteins
is
the
hallmark
Parkinson’s
disease
(PD)
illnesses,
respectively,
being
complex
neurological
disorders.
A
primary
cause
protein
aggregation,
brain
injury,
cognitive
loss
in
illnesses
misfolding
normal
cellular
(PrP
C
)
into
an
infectious
form
Sc
).
Aggregation
causes
disruptions
processes
(PD),
leading
to
dopamine-producing
neurons
motor
symptoms.
Alteration
composition
or
activity
gut
microbes
may
weaken
intestinal
barrier
make
it
possible
for
prions
go
from
brain.
The
gut-brain
axis
linked
neuroinflammation;
metabolites
produced
by
microbiota
affect
aggregation
α-synuclein,
regulate
inflammation
immunological
responses,
influence
course
neurotoxicity
proteins,
even
if
their
targets
are
distinct
proteins.
This
thorough
analysis
explores
interactions
that
exist
between
neurodegenerative
particularly
involvement
microbiota,
a
collection
bacteria,
archaea,
fungi,
viruses
etc.,
various
becoming
increasingly
recognized.
microbiome
influences
neuroinflammation,
neurotransmitter
synthesis,
mitochondrial
function,
integrity
through
axis,
which
contributes
development
progression
disease.
review
delves
molecular
mechanisms
underlie
these
relationships,
emphasizing
effects
microbial
such
as
bacterial
lipopolysaccharides
(LPS),
short-chain
fatty
acids
(SCFAs)
regulating
functioning.
Additionally,
looks
at
how
environmental
dietary
decisions
whether
they
could
be
risk
factors
illnesses.
study
concludes
highlighting
critical
role
plays
It
also
provides
promising
direction
future
research
treatment
approaches.
People
afflicted
difficult
ailments
find
hope
new
preventive
therapeutic
approaches
diseases
better
understood.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(7), P. 1070 - 1070
Published: April 5, 2024
Background:
The
equilibrium
between
gut
microbiota
(GM)
and
the
host
plays
a
pivotal
role
in
maintaining
overall
health,
influencing
various
physiological
metabolic
functions.
Emerging
research
suggests
that
exercise
modulates
abundance
functionality
of
bacteria,
yet
comprehensive
effects
on
GM
diversity
remain
to
be
synthesized.
Objectives
Design:
study
aims
quantitatively
examine
effect
adults
using
systemic
review
meta-analysis
approach.
Methods:
PubMed,
Ebsco,
Embase,
Web
Science,
Cochrane
Central
Register
Controlled
Trials,
China
National
Knowledge
Infrastructure,
Wanfang
Data
were
searched
from
their
inception
September
2023.
Exercise
intervention
studies
with
control
group
describe
compare
composition
adults,
16S
rRNA
gene
sequencing,
included
this
meta-analysis.
Results:
A
total
25
1044
participants.
Based
fixed-effects
model
[Chi2
=
29.40,
df
20
(p
0.08);
I2
32%],
pooled
analysis
showed
compared
group,
can
significantly
increase
alpha
adult
GM,
Shannon
index
as
an
example
[WMD
0.05,
95%
CI
(0.00,
0.09);
Z
1.99
0.05)].
In
addition,
interventions
found
alter
notably
decreasing
Bacteroidetes
increasing
Firmicutes,
indicating
shift
Firmicutes/Bacteroidetes
ratio.
subgroup
indicates
females
older
appear
exhibit
more
significant
changes
Index
observed
OTUs.
Conclusions:
may
promising
way
improve
adults.
particular,
was
increased
after
exercise.
Distinct
responses
based
gender
age
implicated
needed.